Page:United States Statutes at Large Volume 124.djvu/1006

 124 STAT. 980 PUBLIC LAW 111–148—MAR. 23, 2010 ‘‘(ii) CHAIRPERSON AND VICE CHAIRPERSON.—The Secretary shall designate, from among the 24 members appointed under clause (i), one Chairperson of the Board (referred to in this section as the ‘Chairperson’) and one Vice Chairperson. ‘‘(B) TERMS.— ‘‘(i) IN GENERAL.—Each member shall be appointed to serve a 4-year term, except that any member appointed to fill a vacancy occurring prior to the expira- tion of the term for which the member’s predecessor was appointed shall be appointed for the remainder of such term. ‘‘(ii) CONSECUTIVE APPOINTMENTS; MAXIMUM TERMS.—A member may be appointed to serve not more than 3 terms on the Board, and may not serve more than 2 such terms consecutively. ‘‘(C) QUALIFICATIONS.— ‘‘(i) IN GENERAL.—The Secretary shall appoint individuals to the Board based solely upon the individ- ual’s established record of distinguished service in one of the areas of expertise described in clause (ii). Each individual appointed to the Board shall be of distin- guished achievement and have a broad range of dis- ciplinary interests. ‘‘(ii) EXPERTISE.—The Secretary shall select individuals based upon the following requirements: ‘‘(I) For each of the fields of— ‘‘(aa) basic research; ‘‘(bb) medicine; ‘‘(cc) biopharmaceuticals; ‘‘(dd) discovery and delivery of medical products; ‘‘(ee) bioinformatics and gene therapy; ‘‘(ff) medical instrumentation; and ‘‘(gg) regulatory review and approval of medical products, the Secretary shall select at least 1 individual who is eminent in such fields. ‘‘(II) At least 4 individuals shall be recognized leaders in professional venture capital or private equity organizations and have demonstrated experience in private equity investing. ‘‘(III) At least 8 individuals shall represent disease advocacy organizations. ‘‘(3) EX-OFFICIO MEMBERS.— ‘‘(A) APPOINTMENT.—In addition to the 24 Board mem- bers described in paragraph (2), the Secretary shall appoint as ex-officio members of the Board— ‘‘(i) a representative of the National Institutes of Health, recommended by the Secretary of the Depart- ment of Health and Human Services; ‘‘(ii) a representative of the Office of the Assistant Secretary of Defense for Health Affairs, recommended by the Secretary of Defense;